Metagenomi Therapeutics, Inc. Shares Outstanding
Metagenomi Therapeutics, Inc. (MGX) had Shares Outstanding of 37.78 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-10
- 2026-06-30: Shares outstanding (split-adjusted) 37.78M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 37.65M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 37.62M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 37.55M shares; Shares authorized (split-adjusted) 500.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 37.78M shares 10-Q · filed 2026-08-10 | 500.00M shares 10-Q · filed 2026-08-10 |
| 2026-03-31 | 37.65M shares 10-Q · filed 2026-05-11 | 500.00M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 37.62M shares 10-Q · filed 2026-08-10 | 500.00M shares 10-Q · filed 2026-08-10 |
| 2025-09-30 | 37.55M shares 10-Q · filed 2025-11-12 | 500.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 37.53M shares 10-Q · filed 2025-08-12 | 500.00M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 37.38M shares 10-Q · filed 2025-05-13 | 500.00M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 37.42M shares 10-K · filed 2026-03-05 | 500.00M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 37.43M shares 10-Q · filed 2024-11-13 | 500.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 37.46M shares 10-Q · filed 2024-08-14 | 500.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 37.47M shares 10-Q · filed 2024-05-14 | 500.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 3.40M shares 10-K · filed 2025-03-17 | 66.00M shares 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |